Immutep Ltd Adr Stock Performance
| IMMP Stock | USD 2.09 0.02 0.97% |
On a scale of 0 to 100, Immutep holds a performance score of 6. The company retains a Market Volatility (i.e., Beta) of -0.95, which attests to possible diversification benefits within a given portfolio. As the market becomes more bullish, returns on owning Immutep are expected to decrease slowly. On the other hand, during market turmoil, Immutep is expected to outperform it slightly. Please check Immutep's semi variance, and the relationship between the treynor ratio and daily balance of power , to make a quick decision on whether Immutep's current trending patterns will revert.
Risk-Adjusted Performance
6 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Immutep Ltd ADR are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Even with relatively weak primary indicators, Immutep reported solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 2.42 | Five Day Return 6.53 | Year To Date Return (4.07) | Ten Year Return (25.09) | All Time Return (94.72) |
Last Split Factor 3:10 | Dividend Date 2016-12-28 | Last Split Date 2016-12-28 |
1 | Immuteps Efti Shows Excellent Survival Data from INSIGHT-003 Trial in Non-Small Cell Lung Cancer | 11/14/2024 |
2 | Immutep reports promising lung cancer trial results | 11/15/2024 |
3 | Immutep Announces Initiation of TACTI-004 Phase III Trial in First Line Non-Small Cell Lung Cancer | 12/10/2024 |
4 | Immutep and Monash University Announce First Publication Detailing How Human LAG-3 Binds to MHC ... | 12/16/2024 |
5 | Patient Enrolment Completed for INSIGHT-003 | 01/06/2025 |
| Begin Period Cash Flow | 123.4 M |
Immutep |
Immutep Relative Risk vs. Return Landscape
If you would invest 183.00 in Immutep Ltd ADR on November 3, 2024 and sell it today you would earn a total of 26.00 from holding Immutep Ltd ADR or generate 14.21% return on investment over 90 days. Immutep Ltd ADR is currently generating 0.2907% in daily expected returns and assumes 3.7891% risk (volatility on return distribution) over the 90 days horizon. In different words, 33% of stocks are less volatile than Immutep, and 95% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Immutep Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Immutep's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Immutep Ltd ADR, and traders can use it to determine the average amount a Immutep's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0767
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | IMMP | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.79 actual daily | 33 67% of assets are more volatile |
Expected Return
| 0.29 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Immutep is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Immutep by adding it to a well-diversified portfolio.
Immutep Fundamentals Growth
Immutep Stock prices reflect investors' perceptions of the future prospects and financial health of Immutep, and Immutep fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Immutep Stock performance.
| Return On Equity | -0.26 | ||||
| Return On Asset | -0.17 | ||||
| Operating Margin | (13.53) % | ||||
| Current Valuation | 196.54 M | ||||
| Shares Outstanding | 145.46 M | ||||
| Price To Earning | (152.55) X | ||||
| Price To Book | 2.51 X | ||||
| Price To Sales | 81.29 X | ||||
| Revenue | 3.84 M | ||||
| Gross Profit | (37.7 M) | ||||
| EBITDA | (44.54 M) | ||||
| Net Income | (42.72 M) | ||||
| Cash And Equivalents | 80 M | ||||
| Cash Per Share | 0.92 X | ||||
| Total Debt | 1.59 M | ||||
| Debt To Equity | 0.02 % | ||||
| Current Ratio | 14.16 X | ||||
| Book Value Per Share | 0.13 X | ||||
| Cash Flow From Operations | (34.82 M) | ||||
| Earnings Per Share | (0.25) X | ||||
| Market Capitalization | 312.3 M | ||||
| Total Asset | 201.58 M | ||||
| Retained Earnings | (382.65 M) | ||||
| Working Capital | 180.86 M | ||||
| Current Asset | 1.89 M | ||||
| Current Liabilities | 1.04 M | ||||
About Immutep Performance
Assessing Immutep's fundamental ratios provides investors with valuable insights into Immutep's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Immutep is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.26) | (0.27) | |
| Return On Capital Employed | (0.29) | (0.31) | |
| Return On Assets | (0.24) | (0.26) | |
| Return On Equity | (0.26) | (0.28) |
Things to note about Immutep Ltd ADR performance evaluation
Checking the ongoing alerts about Immutep for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Immutep Ltd ADR help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Immutep Ltd ADR had very high historical volatility over the last 90 days | |
| The company reported the previous year's revenue of 3.84 M. Net Loss for the year was (42.72 M) with loss before overhead, payroll, taxes, and interest of (37.7 M). | |
| Immutep Ltd ADR currently holds about 80 M in cash with (34.82 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.92. | |
| Immutep Ltd ADR has a frail financial position based on the latest SEC disclosures | |
| Latest headline from gurufocus.com: Patient Enrolment Completed for INSIGHT-003 |
- Analyzing Immutep's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Immutep's stock is overvalued or undervalued compared to its peers.
- Examining Immutep's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Immutep's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Immutep's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Immutep's stock. These opinions can provide insight into Immutep's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Immutep Stock Analysis
When running Immutep's price analysis, check to measure Immutep's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immutep is operating at the current time. Most of Immutep's value examination focuses on studying past and present price action to predict the probability of Immutep's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immutep's price. Additionally, you may evaluate how the addition of Immutep to your portfolios can decrease your overall portfolio volatility.